• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/16/21 5:28:25 PM ET
    $LSAQ
    Business Services
    Finance
    Get the next $LSAQ alert in real time by email
    SC 13G 1 tm216984d1_sc13g.htm SC 13G

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO §240.13d-2

     

    LifeSci Acquisition II Corp.

    (Name of Issuer)

     

    Common Stock, $0.0001 par value
    (Title of Class of Securities)

     

    53229E103
    (CUSIP Number)

     

    December 31, 2020
    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1 (b)
    ¨Rule 13d-1 (c)
    xRule 13d-1 (d)

     

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    (Continued on following page(s))
    Page 1 of 7 Pages

     

     

     

     

     

    CUSIP No. 53229E103  13G  Page 2 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

     

    LifeSci Holdings LLC

     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)            x
    (b)            ¨
    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

     

    1,772,034

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    1,772,034

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,772,034

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

     


    ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    17.7%

    12

    TYPE OF REPORTING PERSON*

     

    OO

     

     

     

    CUSIP No. 53229E103  13G  Page 3 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

    Andrew McDonald

     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)            x
    (b)            ¨
    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    1,772,034(1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    1,772,034(1)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,772,034(1)

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

     


    ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    17.7%

    12

    TYPE OF REPORTING PERSON*

     

    IN

     

    (1) Consists of shares owned by LifeSci Holdings LLC (“LifeSci Holdings”). Andrew McDonald shares voting and dispositive power over the shares owned by the LifeSci Holdings.

     

     

      

    CUSIP No. 53229E103  13G  Page 4 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

    Michael Rice

     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)            x
    (b)            ¨
    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    1,772,034(1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    1,772,034(1)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,772,034(1)

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

     


    ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    17.7%

    12

    TYPE OF REPORTING PERSON*

     

    IN

     

    (1) Consists of shares owned by LifeSci Holdings. Michael Rice shares voting and dispositive power over the shares owned by the LifeSci Holdings.

     

     

     

    CUSIP No. 53229E103  13G  Page 5 of 7 Pages

     

    Explanatory Note

    Item 1.

    (a)           Name of Issuer: LifeSci Acquisition II Corp.

     

    (b)           Address of Issuer's Principal Executive Offices:

     

    250 W. 55th St., #3401

    New York, NY 10019

     

    Item 2.

     

    (a)           Name of Person Filing:

    This statement is filed by:

     

    (i) LifeSci Holdings LLC

    (ii) Andrew McDonald

    (iii) Michael Rice

     

    (b)           Address of Principal Business Office or if none, Residence:

     

    c/o LifeSci Acquisition II Corp.

    250 W. 55th St., #3401

    New York, NY 10019

     

    (c)           Citizenship:

     

    LifeSci Holdings LLC – Delaware

    Andrew McDonald – United States

    Michael Rice – United States

     

    (d)           Title of Class of Securities: Common Stock, $0.0001 par value

     

    (e)           CUSIP Number: 53229E103

     

    Item 3.                    Not Applicable

     

    Item 4.                    Ownership.

     

    (a)Amount Beneficially Owned:

     

    LifeSci Holdings LLC – 1,772,034 shares.

     

    Andrew McDonald – 1,772,034 shares. Consists of shares owned by LifeSci Holdings LLC.

     

    Michael Rice – 1,772,034 shares. Consists of shares owned by LifeSci Holdings LLC.

     

    (b)Percent of Class:

     

    LifeSci Holdings LLC – 17.7%

     

    Andrew McDonald – 17.7%

     

    Michael Rice – 17.7%

     

    The foregoing percentages are based on 10,011,301 shares of common stock outstanding as of December 31, 2020.

     

     

     

    CUSIP No. 53229E103  13G  Page 6 of 7 Pages

     

    (c)           Number of shares as to which such person has:

     

    (i)            sole power to vote or to direct the vote:

     

    LifeSci Holdings LLC – 1,772,034

     

    Andrew McDonald – 0

     

    Michael Rice – 0

     

    (ii)           shared power to vote or to direct the vote:

     

    LifeSci Holdings LLC – 0

     

    Andrew McDonald – 1,772,034

     

    Michael Rice – 1,772,034

     

    (iii)          sole power to dispose or to direct the disposition of:

     

    LifeSci Holdings LLC – 1,772,034

     

    Andrew McDonald – 0

     

    Michael Rice – 0

     

    (iv)          shared power to dispose or to direct the disposition of:

     

    LifeSci Holdings LLC – 0

     

    Andrew McDonald – 1,772,034

     

    Michael Rice – 1,772,034

     

    Item 5.                    Ownership of Five Percent or Less of a Class: Not Applicable

     

    Item 6.                    Ownership of More than Five Percent on Behalf of Another Person: Not Applicable

     

    Item 7.                    Identification and Classification of Subsidiary Which Acquired the Securities: Not Applicable

     

    Item 8.                    Identification and Classification of Members of the Group: Not Applicable

     

    Item 9.                    Notice of Dissolution of Group: Not Applicable

     

    Item 10.                  Certifications: Not Applicable

     

     

       

    CUSIP No. 53229E103  13G  Page 7 of 7 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    February 16, 2021

     

      LIFESCI HOLDINGS LLC
       
      By: /s/ Andrew McDonald
      Name: Andrew McDonald
      Title: Managing Member
       
      By: /s/ Michael Rice
      Name: Michael Rice
      Title: Managing Member
       
       
      /s/ Andrew McDonald
      Andrew McDonald
       
      /s/ Michael Rice
      Michael Rice

      

     

     

    Get the next $LSAQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LSAQ

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LSAQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider De Silva Bhooshitha B.

    3 - Science 37 Holdings, Inc. (0001819113) (Issuer)

    10/18/21 4:48:37 PM ET
    $LSAQ
    Business Services
    Finance

    SEC Form 3: New insider Pharmaceutical Product Development, Llc claimed ownership of 17,314,315 shares

    3 - Science 37 Holdings, Inc. (0001819113) (Issuer)

    10/18/21 4:46:17 PM ET
    $LSAQ
    Business Services
    Finance

    SEC Form 3: New insider Lux Capital Management, Llc claimed ownership of 15,164,556 shares

    3 - Science 37 Holdings, Inc. (0001819113) (Issuer)

    10/18/21 4:32:23 PM ET
    $LSAQ
    Business Services
    Finance

    $LSAQ
    SEC Filings

    View All

    LifeSci Acquisition II Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Changes in Registrant’s Certifying Accountant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    8-K - Science 37 Holdings, Inc. (0001819113) (Filer)

    10/13/21 5:26:13 PM ET
    $LSAQ
    Business Services
    Finance

    LifeSci Acquisition II Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure

    8-K - Lifesci Acquisition II Corp. (0001819113) (Filer)

    10/6/21 4:47:03 PM ET
    $LSAQ
    Business Services
    Finance

    SEC Form 424B3 filed by LifeSci Acquisition II Corp.

    424B3 - Lifesci Acquisition II Corp. (0001819113) (Filer)

    9/24/21 7:01:10 AM ET
    $LSAQ
    Business Services
    Finance

    $LSAQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE

    Science 37 to debut on Nasdaq as a publicly traded company under ticker symbol "SNCE"Business combination will provide Science 37 with approximately $235 million in cash proceeds to support continued growthScience 37 to fuel its mission to enable universal access to clinical research which has proven to accelerate patient enrollment, minimize patient burden, and include underserved patient populations Investments targeted to enhance the Science 37 Operating System to decentralize clinical trial execution and enable more agile clinical trials LOS ANGELES and NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Science 37, Inc., the Operating System for today's agile clinical trials, announced today

    10/7/21 8:00:00 AM ET
    $LSAQ
    Business Services
    Finance

    LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination

    NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- LifeSci Acquisition II Corp. (NASDAQ:LSAQ), a blank check company formed for the purpose of pursuing targets that are focused on healthcare innovation, today announced the confidential submission with the U.S. Securities and Exchange Commission ("SEC") of a draft registration statement on Form S-4 (the "Registration Statement") relating to its previously announced proposed business combination with Science 37, Inc. About LifeSci Acquisition II Corp. LifeSci Acquisition II Corp. (NASDAQ:LSAQ) is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganizat

    6/16/21 9:00:00 AM ET
    $LSAQ
    Business Services
    Finance

    Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future

    Transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing Positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial technology platform, extend into new adjacencies, and power the next generation in clinical research $80 million via LifeSci Acquisition II Corp., a special purpose acquisition company with no public warrants $200 million via fully committed and upsized PIPE from leading institutional and strategic investors including Redmile Group; funds and accounts managed by BlackRock; Casdin Capital; dRx Capital (Novartis Pharma AG); LifeSci Venture Partners; Lux Capital; Mubadala Capital, the asset manageme

    5/7/21 7:55:00 AM ET
    $LSAQ
    Business Services
    Finance

    $LSAQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by LifeSci Acquisition II Corp.

    SC 13D - Science 37 Holdings, Inc. (0001819113) (Subject)

    10/18/21 4:30:20 PM ET
    $LSAQ
    Business Services
    Finance

    SEC Form SC 13D filed by LifeSci Acquisition II Corp.

    SC 13D - Science 37 Holdings, Inc. (0001819113) (Subject)

    10/18/21 4:16:02 PM ET
    $LSAQ
    Business Services
    Finance

    SEC Form SC 13D filed by LifeSci Acquisition II Corp.

    SC 13D - Science 37 Holdings, Inc. (0001819113) (Subject)

    10/18/21 4:05:14 PM ET
    $LSAQ
    Business Services
    Finance